NEJM -- The Rosiglitazone Story -- Lessons from an FDA Advisory Committee Meeting -- Table 1

Table 1. Results of FDA Meta-Analysis of 42 Randomized Trials Comparing Rosiglitazone with Other Drugs or Placebo.